Flushing Financial arrived at its Q1 2026 earnings release already under the microscope — and the numbers didn't help.
The bank reported Tuesday after the close. Q1 adjusted EPS came in at $0.29, missing the consensus by $0.06. Revenue of $57.0 million trailed estimates by nearly $5 million. The one bright spot was net interest margin, which expanded 16 basis points year-over-year to underpin net interest income of $55.2 million — a genuine improvement on the $53.0 million recorded a year ago, when the bank posted a net loss. Still, the headline miss was enough to push shares down 2.2% on Wednesday to $16.00. That said, the stock remains up 1.1% on the week and has gained 7.5% over the past month, meaning longer-term holders haven't been badly hurt.
Options positioning told this story before it happened. The put/call ratio shot to 0.63 on April 29, a reading 3.25 standard deviations above its 20-day average of 0.33 — and the highest level recorded in the past year. The market was loading up on downside protection into the print. The rapid shift is stark: for most of April the PCR held in a narrow range around 0.36, and before that it ran below 0.23 through March. The jump to 0.63 the day the earnings landed is the clearest sign that traders sensed the risk going in.
Short interest doesn't reinforce a particularly aggressive bear case. Estimated shares short have dropped about 11% over the past week, falling to roughly 854,000 shares as of April 28, with a further dip to around 854,000 on the day of reporting. The notable context is that short interest itself roughly doubled from early April levels — it stood near 643,000 shares at the start of April and jumped sharply around April 10, eventually stabilising near 960,000 before pulling back this week. Borrow costs are low at 0.54% annualised, down around 20% over the past month, and availability in the lending market is wide — this is not a crowded or expensive short. The ORTEX short score has eased slightly over the past week, sitting at 34.2, further reinforcing that shorts aren't building pressure here.
Analyst coverage is thin and the most recent formal action dates to January 2026, when Keefe, Bruyette & Woods raised its price target to $16.80 while maintaining a Market Perform rating — a consensus call that now sits almost exactly at the current share price, offering 2.7% return potential by the Street's measure. With two hold ratings and no fresh moves following the Q1 miss, the Street's posture is essentially neutral wait-and-see. Notably, some historical targets from other firms date back to 2024 and may not reflect the current setup.
On the ownership front, Wellington Management initiated a sizable position of 1.69 million shares as of January, making it a 5% holder alongside BlackRock at 8.9% and Vanguard at 5.5%. State Street added 240,000 shares in the most recent quarter, a notable increment for a name of this size. Insider activity has been exclusively sales — the CEO, CFO, COO and several senior executives all sold small parcels on January 28, likely tied to plan-based disposals around the earnings calendar.
What to watch now: the gap between FFIC's improving NIM story and its stubborn revenue shortfall is the real tension heading into the Q2 July 24 report date — whether the margin expansion can translate into top-line beat will define how the stock is priced from here.
See the live data behind this article on ORTEX.
Open FFIC on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
